BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT

Title

Atherogenic effect of Arecoline: A computational study

 

Authors

Manabendra Dutta Choudhury1*, Pankaj Chetia2, Karabi Dutta Choudhury3, Anupam Das Talukdar2 & Mohan Datta-choudhari4

 

Affiliation

1Institute of Pharmaceutical Engineering Science, University of Bradford, UK; 2Bioinformatics Centre, Assam University, Silchar, India; 3Department of Mathematics, Assam University, Silchar, India; 4Stroke unit, Central Manchester University Hospital NHS Foundation Trust, Oxford Road, Manchester, UK.

 

Email

drmdc@bioinfoaus.ac.in; *Corresponding author

 

Article Type

Hypothesis

 

Date

Received February 22, 2012; Accepted March 09, 2012; Published March 17, 2012

 

Abstract

There are over 600 million people worldwide covering Asian and Oceanic countries including India have the habit of chewing areca nut as masticator in different forms. Arecoline (C8H13NO2) has been reported as one of the abundant constituents of areca nut. A good number of scientific publications have made Arecoline responsible for oral cancer. Based on observation from clinical situation in North East India, one of the most betel quid chewing region of the country, we suspected a link between consumption of areca nut and Cerebro Vascular Disease like stroke. Therefore, we considered Low Density Lipoprotein (LDL) receptor as target and Arecoline as ligand and studied ligand –target interaction using computational tools. Also we considered High Density Lipoprotein (HDL) receptor as another target to see if Arecoline has any binding potential with it over and above LDL receptor. Docking result indicated that Arecoline and Cholesterol both, have affinity towards extracellular domain of Human LDL receptor but affinity of Arecoline is much higher (-12.3560.) than that of Cholesterol(-0.1810). Docking of Arecoline and 1, 2-Hexyl-1-cyclopentanone thiosemicarbazone (thiosemicarbazone) with Bovine HDL receptor showed that Arecoline also has the potential (Score, -6.2690Kcal/Mol) to block HDL receptor though its potential is less than that (score, -10.0509 Kcal/Mol) of control (thiosemicarbazone). We, therefore, suggest that by inhibiting endocytosis of LDL cholesterol because of blocking LDL receptor function and also by preventing LDL cholesterol uptake by liver from blood because of interference with HDL receptor, Arecoline may contribute to atherosclerosis. The study therefore, indicates a positive correlation between chewing of betel quid and Cerebro Vascular Disease.

 

Keywords

Arecoline, Atherogenic effect, LDL receptor, HDL receptor, Cerebro Vascular Disease, Insilico

 

Citation

Choudhury et al. Bioinformation 8(5): 229-232 (2012)
 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.